Montreal, May 6, 2026 – Researchers from McGill University have introduced a groundbreaking new class of molecules that could significantly reshape drug discovery and development. The technology,...
In an effort to support D2R researchers in meaningfully incorporating the principles of Equity, Diversity, and Inclusion (EDI) into their research design and research practice, the D2R EDI...
Montreal – April 29, 2026 | McGill University’s DNA to RNA Initiative (D2R) has invested nearly $6 million in funding to support four groundbreaking research projects that will advance RNA-based...
D2R will hold its second Research Symposium where it will bring more than 250 participants together to share and discuss the innovative research being conducted across the D2R Initiative.Centre...
In an effort to support researchers in incorporating the principles of Equity, Diversity, and Inclusion (EDI) into their work as RNA research, the D2R EDI Community of Practice is organizing an...
Intellectual property and in particular patents remain a cornerstone of innovation and commercialization in the life sciences.D2R Office, 1010 Sherbrooke O, 18th floor, CA/dna-to-rnaCategory:...
Have an innovative idea and not sure how the patenting process works? Join D2R and Lavery to learn how patent strategy supports scientific impact and how early choices impact downstream...
AReNA is launching a series of free webinars dedicated to RNA therapies, spotlighting leading international companies to fuel innovation, inspire the local ecosystem, and create tangible...
The D2R community is saddened by the passing of Professor Robert Sladek, a founding member of the McGill Genome Centre and a valued member of the Victor Phillip Dahdaleh Institute of Genomic...
RSS